Patrick B Donnelly
Stock Analyst at Citi
(3.94)
# 1,800
Out of 4,491 analysts
571
Total ratings
52.4%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by Patrick B Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintained: Hold | $44 → $60 | $58.25 | +3.00% | 30 | Jul 8, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $265 | $228.68 | +15.88% | 24 | Jul 8, 2026 | |
| QDEL QuidelOrtho | Maintained: Hold | $13 → $18 | $17.00 | +5.88% | 17 | Jul 8, 2026 | |
| GH Guardant Health | Maintained: Buy | $150 → $215 | $162.92 | +31.97% | 23 | Jul 8, 2026 | |
| AVTR Avantor | Maintained: Hold | $9 → $11 | $10.20 | +7.84% | 24 | Jul 8, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $24 → $45 | $37.83 | +18.95% | 27 | Jul 8, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $70 → $73 | $70.61 | +3.38% | 23 | Jun 29, 2026 | |
| ICLR ICON Public Limited Company | Rated: Hold | $140 → $165 | $168.72 | -2.20% | 20 | Jun 25, 2026 | |
| NTRA Natera | Maintained: Buy | $300 | $281.27 | +6.66% | 4 | May 28, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $23 | $18.02 | +27.64% | 13 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $265 → $230 | $194.19 | +18.44% | 30 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.48 | - | 13 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,550 | $1,295.59 | +19.64% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $28 | $17.47 | +60.27% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $55 | $43.01 | +27.88% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $41 → $95 | $191.76 | -50.46% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $38 | $38.72 | -1.86% | 19 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $375 → $400 | $356.08 | +12.33% | 7 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $375 → $300 | $292.50 | +2.56% | 27 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 | $374.93 | +13.35% | 18 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $200 | $208.23 | -3.95% | 22 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $19.59 | +32.72% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $685 | $516.62 | +32.59% | 31 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $185 | $131.14 | +41.07% | 37 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $215 | $212.38 | +1.23% | 20 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $325 | $283.86 | +14.49% | 12 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 | $112.05 | n/a | 21 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $6 | $4.32 | n/a | 9 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $4.25 | $2.01 | n/a | 5 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $37.92 | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $13.98 | n/a | 9 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 → $36 | $20.82 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $32 | $5.86 | n/a | 1 | Nov 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 | $0.0004 | n/a | 1 | Nov 30, 2018 |
Bruker
Jul 8, 2026
Maintained: Hold
Price Target: $44 → $60
Current: $58.25
Upside: +3.00%
Charles River Laboratories International
Jul 8, 2026
Maintained: Buy
Price Target: $265
Current: $228.68
Upside: +15.88%
QuidelOrtho
Jul 8, 2026
Maintained: Hold
Price Target: $13 → $18
Current: $17.00
Upside: +5.88%
Guardant Health
Jul 8, 2026
Maintained: Buy
Price Target: $150 → $215
Current: $162.92
Upside: +31.97%
Avantor
Jul 8, 2026
Maintained: Hold
Price Target: $9 → $11
Current: $10.20
Upside: +7.84%
10x Genomics
Jul 8, 2026
Maintained: Hold
Price Target: $24 → $45
Current: $37.83
Upside: +18.95%
Bio-Techne
Jun 29, 2026
Downgraded: Hold
Price Target: $70 → $73
Current: $70.61
Upside: +3.38%
ICON Public Limited Company
Jun 25, 2026
Rated: Hold
Price Target: $140 → $165
Current: $168.72
Upside: -2.20%
Natera
May 28, 2026
Maintained: Buy
Price Target: $300
Current: $281.27
Upside: +6.66%
Sotera Health Company
May 28, 2026
Maintained: Buy
Price Target: $23
Current: $18.02
Upside: +27.64%
May 27, 2026
Initiated Coverage: Buy
Price Target: $265 → $230
Current: $194.19
Upside: +18.44%
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.48
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $1,550
Current: $1,295.59
Upside: +19.64%
May 8, 2026
Maintained: Buy
Price Target: $35 → $28
Current: $17.47
Upside: +60.27%
May 6, 2026
Maintained: Buy
Price Target: $60 → $55
Current: $43.01
Upside: +27.88%
May 4, 2026
Rated: Sell
Price Target: $41 → $95
Current: $191.76
Upside: -50.46%
Apr 29, 2026
Maintained: Hold
Price Target: $55 → $38
Current: $38.72
Upside: -1.86%
Apr 24, 2026
Maintained: Buy
Price Target: $375 → $400
Current: $356.08
Upside: +12.33%
Apr 7, 2026
Downgraded: Hold
Price Target: $375 → $300
Current: $292.50
Upside: +2.56%
Apr 7, 2026
Rated: Buy
Price Target: $425
Current: $374.93
Upside: +13.35%
Apr 7, 2026
Rated: Hold
Price Target: $200
Current: $208.23
Upside: -3.95%
Apr 7, 2026
Maintained: Buy
Price Target: $26
Current: $19.59
Upside: +32.72%
Apr 6, 2026
Maintained: Buy
Price Target: $685
Current: $516.62
Upside: +32.59%
Mar 11, 2026
Maintained: Buy
Price Target: $185
Current: $131.14
Upside: +41.07%
Feb 11, 2026
Maintained: Hold
Price Target: $215
Current: $212.38
Upside: +1.23%
Jan 2, 2026
Maintained: Buy
Price Target: $325
Current: $283.86
Upside: +14.49%
May 22, 2025
Maintained: Buy
Price Target: $135
Current: $112.05
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $9 → $6
Current: $4.32
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: $1.5 → $4.25
Current: $2.01
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $62
Current: $37.92
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $6
Current: $13.98
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $32 → $36
Current: $20.82
Upside: n/a
Nov 30, 2018
Upgraded: Hold
Price Target: $32
Current: $5.86
Upside: n/a
Nov 30, 2018
Maintained: Hold
Price Target: $4.5
Current: $0.0004
Upside: n/a